Glenmark Pharmaceuticals

Glenmark got certified following a rigorous five‐stage review, and is only the second Indian pharma company to receive this…

With this approval, Glenmark is eligible for 180-days of generic drug exclusivity for Calcipotriene and Betamethasone Dipropionate…

Glenmark’s current portfolio consists of 182 products authorised for distribution in the US marketplace

Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (US FDA) for…

Announce exclusive US distribution pact, distribution expected to start during the second half of 2023

Dr Monika Tandon, Group Vice President - Clinical Development, Glenmark Pharmaceuticals, believes that optimism with a touch…

Mahalaxmi Andheria, Vice President – Intellectual Property Management, Glenmark Pharmaceuticals accentuates that leaders…

Dr Rajkiran Jain, Group VP - Regulatory Affairs, Glenmark Pharmaceuticals highlights that apart from subject matter expertise,…

Dr Jaya Abraham, Sr VP, Formulation Development, Glenmark Pharmaceuticals emphasises on the importance of a clear vision,…

Glenmark’s first tentative approval letter for Saxagliptin Tablets, 2.5 mg and 5 mg was received on June 12, 2017